Fluid management specialist Bürkert has introduced a strategic funding in Inexperienced Elephant Biotech, a German biotechnology startup creating sustainable cell cultivation programs. The partnership goals to advance cell cultivation processes for pharmaceutical and biotech purposes.
Inexperienced Elephant Biotech’s major innovation is the CellScrew cultivation system, which affords elevated development floor space for adherent cell cultures in comparison with conventional vessels. The CellScrew cultivation system makes use of 3D printing to fabricate parts from PLA. The corporate was based in 2021 at Technische Hochschule Mittelhessen College of Utilized Sciences.
The CellScrew system addresses environmental issues in pharmaceutical manufacturing by its supplies and design. In accordance with co-founder Felix Wollenhaupt, “Our CellScrew is, firstly, made out of much less uncooked materials, which suggests much less waste in and of itself. Secondly, we use PLA, which reduces the carbon footprint by round 90 % in comparison with typical programs.”
The collaboration will give attention to increasing the CellScrew’s capabilities into a whole bioreactor system. Co-founder Dr. Joel Eichmann states, “Along with Bürkert, we wish to flip the CellScrew right into a fully-fledged bioreactor. This requires liquids to be exchanged, gases to be monitored, and processes to be regulated.”
The partnership combines Inexperienced Elephant Biotech’s cell cultivation know-how with Bürkert’s experience in fluid management programs. The joint improvement efforts intention to create manufacturing platforms appropriate for pharmaceutical purposes, with a specific give attention to customized drugs manufacturing.
Supply: expresspharma.in
